Nymox Pharmaceuticals

$2.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.26%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell NYMX and other stocks, options, and ETFs commission-free!

About NYMX

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. Read More It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas. The listed name for NYMX is Nymox Pharmaceutical Corporation Common Stock (Bahamas).

Employees
4
Headquarters
Nassau, New Providence
Founded
1995
Market Cap
179.35M
Price-Earnings Ratio
Dividend Yield
Average Volume
126.92K
High Today
$2.40
Low Today
$2.29
Open Price
$2.40
Volume
82.97K
52 Week High
$4.79
52 Week Low
$1.66

Collections

NYMX Earnings

-$0.08
-$0.05
-$0.03
$0.00
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Estimated
per share
Actual
Expected Nov 12, After Hours

You May Also Like